Literature DB >> 15922475

Developmental expression of canalicular transporter genes in human liver.

Huey-Ling Chen1, Hui-Ling Chen, Yu-Jung Liu, Chun-Hsiang Feng, Chao-Yi Wu, Ming-Kwang Shyu, Ray-Hwang Yuan, Mei-Hwei Chang.   

Abstract

BACKGROUND/AIMS: BSEP, MRP2, and MDR3 are major hepatic canalicular transporters mediating bile secretion. Their expression in human liver during development has not been reported.
METHODS: Human liver samples from fetus at gestational age 14-20 weeks, adult livers and liver samples of infants with biliary atresia were tested for mRNA expression of BSEP, MDR3, MRP2, NTCP, FIC1, and FXR genes by using real-time RT-PCR. Immunohistochemical staining of BSEP, MDR3, and MRP2 were performed on fetal and adult livers.
RESULTS: All the genes tested were expressed at mid-gestational age. MDR3 and NTCP showed significant lower levels in fetal livers compared to adults. In patients with biliary atresia, all the genes tested showed higher mean expression levels than adults except for NTCP, but not statistically significant. The immunohistochemical staining of MRP2 in fetal liver was canalicular, BSEP showed both intracellular and canalicular staining, and MDR3 staining was faint, only occasional canalicular pattern could be seen.
CONCLUSIONS: The major canalicular transporter genes are expressed at mid-gestational stage during human fetal development, but are different in expression level and targeting pattern, indicating differential regulation and maturation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15922475     DOI: 10.1016/j.jhep.2005.02.030

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  27 in total

Review 1.  Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein).

Authors:  Ronald P J Oude Elferink; Coen C Paulusma
Journal:  Pflugers Arch       Date:  2006-04-19       Impact factor: 3.657

2.  Higher clearance of micafungin in neonates compared with adults: role of age-dependent micafungin serum binding.

Authors:  Souzan B Yanni; P Brian Smith; Daniel K Benjamin; Patrick F Augustijns; Dhiren R Thakker; Pieter P Annaert
Journal:  Biopharm Drug Dispos       Date:  2011-03-30       Impact factor: 1.627

Review 3.  The bile salt export pump.

Authors:  Bruno Stieger; Yvonne Meier; Peter J Meier
Journal:  Pflugers Arch       Date:  2006-10-19       Impact factor: 3.657

Review 4.  Regulation of hepatic ABCC transporters by xenobiotics and in disease states.

Authors:  Xinsheng Gu; Jose E Manautou
Journal:  Drug Metab Rev       Date:  2010-08       Impact factor: 4.518

5.  RNA-Seq reveals different mRNA abundance of transporters and their alternative transcript isoforms during liver development.

Authors:  Julia Yue Cui; Sumedha S Gunewardena; Byunggil Yoo; Jie Liu; Helen J Renaud; Hong Lu; Xiao-bo Zhong; Curtis D Klaassen
Journal:  Toxicol Sci       Date:  2012-03-27       Impact factor: 4.849

6.  Correlation between Conjugated Bisphenol A Concentrations and Efflux Transporter Expression in Human Fetal Livers.

Authors:  Jamie E Moscovitz; Muna S Nahar; Stuart L Shalat; Angela L Slitt; Dana C Dolinoy; Lauren M Aleksunes
Journal:  Drug Metab Dispos       Date:  2016-02-05       Impact factor: 3.922

Review 7.  Developmental pharmacokinetics in pediatric populations.

Authors:  Hong Lu; Sara Rosenbaum
Journal:  J Pediatr Pharmacol Ther       Date:  2014 Oct-Dec

8.  Regulation of hepatic bile acid transporters Ntcp and Bsep expression.

Authors:  Xingguo Cheng; David Buckley; Curtis D Klaassen
Journal:  Biochem Pharmacol       Date:  2007-08-19       Impact factor: 5.858

9.  Metabolism of 17alpha-hydroxyprogesterone caproate, an agent for preventing preterm birth, by fetal hepatocytes.

Authors:  Shringi Sharma; Ewa C S Ellis; Kenneth Dorko; Shimin Zhang; Donald R Mattison; Steve N Caritis; Raman Venkataramanan; Stephen C Strom
Journal:  Drug Metab Dispos       Date:  2010-01-22       Impact factor: 3.922

Review 10.  Bile formation and secretion.

Authors:  James L Boyer
Journal:  Compr Physiol       Date:  2013-07       Impact factor: 9.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.